Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

58 results about "Toxicity" patented technology

Toxicity is the degree to which a chemical substance or a particular mixture of substances can damage an organism. Toxicity can refer to the effect on a whole organism, such as an animal, bacterium, or plant, as well as the effect on a substructure of the organism, such as a cell (cytotoxicity) or an organ such as the liver (hepatotoxicity). By extension, the word may be metaphorically used to describe toxic effects on larger and more complex groups, such as the family unit or society at large. Sometimes the word is more or less synonymous with poisoning in everyday usage.

Uses for and article of manufacture including her2 dimerization inhibitor pertuzumab

InactiveUS20130095172A1Prolong progression-free survivalReduce riskOrganic active ingredientsImmunoglobulins against cell receptors/antigens/surface-determinantsMetastatic gastric cancerHER2 Positive Breast Cancer
The present application describes uses for and articles of manufacture including Pertuzumab, a first-in-class HER2 dimerization inhibitor. In particular, the application describes methods for extending progression free survival in a HER2-positive breast cancer patient population; combining two HER2 antibodies to treat HER2-positive cancer without increasing cardiac toxicity; treating early-stage HER2-positive breast cancer; treating HER2-positive cancer by co-administering a mixture of Pertuzumab and Trastuzumab from the same intravenous bag; treating HER2-positive metastatic gastric cancer; treating HER2-positive breast cancer with Pertuzumab, Trastuzumab and Vinorelbine; treating HER2-positive breast cancer with Pertuzumab, Trastuzumab and aromatase inhibitor; and treating low HER3 ovarian, primary peritoneal, or fallopian tube cancer. It also describes an article of manufacture comprising a vial with Pertuzumab therein and a package insert providing safety and / or efficacy data thereon; a method of making the article of manufacture; and a method of ensuring safe and effective use of Pertuzumab related thereto. In addition the application describes an intravenous (IV) bag containing a stable mixture of Pertuzumab and Trastuzumab suitable for administration to a cancer patient.
Owner:GENENTECH INC

Preparation method of submicron CuS (copper sulphide) classification ball

InactiveCN102040239ARich in natureEasy to operateCopper sulfidesSolubilityElectrical conductor
The invention discloses a preparation method of submicron CuS (copper sulphide) classification balls. The method comprises the following steps: adding polymer into a good solvent to dissolve and remove big gel particles; adding copper source solution to the good solvent and stirring; adding sulfur source solution and then stirring; reacting the reaction liquid under 100-1,000 KPa at 100-200 DEG C; naturally cooling to the room temperature to obtain black precipitate; and washing and drying the precipitate to obtain the classification balls. The classification balls has the advantages of cheap and readily available templates, environmental friendliness, safety without toxicity, renewability and high water solubility, the contents of raw materials are abundant in nature and the operation of the reaction system is simple; the size and structure of the prepared classification ball are adjustable: the diameter can be controlled by adjusting the molar weight of the added precursor, the template concentration, the reaction temperature and time and the like; the operation is simple; and the prepared classification balls have wide application value in the fields of catalyst, catalyst carrier, optical equipment, sensor, lithium-ion rechargeable battery cathode material, superconductor and the like.
Owner:GUANGZHOU CHEM CO LTD CHINESE ACADEMY OF SCI +1

Chinese patent medicine for treating idiopathic edema

InactiveCN102366617AEdema disappearsReduce puffinessBlood disorderPlant ingredientsDiseaseSide effect
The invention provides a Chinese patent medicine for treating idiopathic edema, which comprises the following components by weight part: 9-15 parts of tribulus terrestris, 8-12 parts of semen psoraleae, 6-10 parts of radix angelicae, 4-8 parts of placenta hominis, 4-8 parts of fleece flower root, 3-5 parts of Maytenus hookeri, 1-3 parts of gen-seng and 1-3 parts of spatholobus stem. Compared with the prior art, the Chinese patent medicine of the present invention aims at internal disease of idiopathic edema, is capable of performing therapies with syndrome differentiation, and has the advantages of fast curative effect, low cost, no toxicity, no side-effect and substantial effect. The Chinese patent medicine for treating idiopathic edema treats both principal and secondary aspect of disease.
Owner:CHENGDU LYUDI TECH

Efficient anaerobic and aerobiotic continuous use industrial wastewater treatment method

ActiveCN109626717AAvoid toxicityAvoid inhibitionWater treatment parameter controlWater treatment compoundsFenton reactionContinuous use
The invention discloses an efficient anaerobic and aerobiotic continuous use industrial wastewater treatment method. Fenton oxidation is adopted for preprocessing wastewater, hydrazine hydrate and other reducibility contaminants in wastewater are removed, the purpose of lowering a COD value can be achieved, and toxicity and inhibition of microorganisms in follow-up biochemistry can be avoided. A fenton reaction catalyst is adopted, the catalyst has the high catalytic activity in the aspect of organic contaminant degradation, and iron digestion and loss in the reaction process can be avoided; the preprocessed wastewater enters the efficient anaerobic and aerobiotic continuous use industrial wastewater treatment technology section, and COD in water can be efficiently removed; compared with the traditional technology, and the method is the treatment technology which is low in cost and high in efficiency and can effectively treat HPPO epoxypropane production wastewater.
Owner:LIAONING ZHONGZHOUDESHUI ENVIRONMENTAL PROTECTION TECH CO LTD

Organic corrosion inhibitor for inhibiting magnesium alloy corrosion and application method of organic corrosion inhibitor in automobile cooling liquid or corrosion aqueous solution

ActiveCN103590045AReduce dosageHigh corrosion inhibition efficiencySolubilityPyrazine
The invention discloses an organic corrosion inhibitor for inhibiting magnesium alloy corrosion and an application method of the organic corrosion inhibitor in an automobile cooling liquid or a corrosion aqueous solution. The corrosion inhibitor consists of the components in percentage by weight: 10-90 percent of pyrazine or/and piperazine and 10-90 percent of water or/and ethanol. According to the application method, the corrosion inhibitor is added into the automobile cooling liquid or the corrosion aqueous solution which immerses a magnesium alloy according to an adding amount of 50-1,000 ppm under a condition at the temperature of -50-90 DEG C. The using amount of the corrosion inhibitor disclosed by the invention is small; the corrosion inhibitor is high in corrosion inhibition efficiency and good in corrosion inhibition effect; under normal temperature, the corrosion inhibition rate can be over 90 percent. The corrosion inhibitor is organic, so that the common shortcomings of an inorganic corrosion inhibitor are overcome; the application temperature range is wide; the organic corrosion inhibitor is applicable to low temperature and normal temperature and can still effectively inhibit corrosion of the magnesium alloy in a solution medium with higher temperature, and the corrosion inhibition rate can be over 80 percent under the higher temperature. The corrosion inhibitor product disclosed by the invention has the advantages of simplicity in production, wide application range, no toxicity, no peculiar smell, complete water solubility, safety and convenience in operation, good economical property and the like.
Owner:武汉钢铁有限公司

Rheumatism plaster and thread gluing type ventilating bagged rheumatism plaster and production method thereof

InactiveCN101214330AGood treatment effectSimple structureHeavy metal active ingredientsAntipyreticAdditive ingredientPinellia
The present invention provides a rheumatism plaster, a thread-gluing breathable bag for packing rheumatism plaster and a production method thereof. The rheumatism plaster includes the following raw materials such as dried pinellia tuber, dried bile arisaema, dried szechuan aconite, dried kusezoff monkshood root, dried nux vomica, sesame oil and yellow lead. The rheumatism plaster is obtained through the following method: a required amount of sesame oil is boiled; then a required amount of dried pinellia tuber, dried bile arisaema, dried szechuan aconite, dried kusezoff monkshood root and dried nux vomica are mixed, poured into boiling sesame oil and fried with mild fire until the drug turns black and carbonized; herb residues are removed after fire is extinguished and a required amount of yellow lead is poured and evenly mixed after the sesame oil cools without boiling. The present invention adopts high-temperature sesame oil to make decoction of the five drugs, so that the toxicity disappears without decreasing the pharmacodynamical effect. The pharmacodynamical ingredients can be fully fried out; in addition, the quality of sesame oil is sticky, the sesame oil gradually dilutes in normal temperature of human body, the pharmacodynamical effect gradually releases and the plaster does not infiltrates the gauze and attach on the skin, so that the present invention achieves the aim of curing rheumatism without allergy. Besides, the present invention also has simple structure and convenient use.
Owner:谢焕青

Water-soluble hypocrellin PLGA nanoparticle and preparation method thereof

InactiveCN103933568AGood biocompatibilitySmall particlesPowder deliveryEnergy modified materialsSolubilitySide effect
The invention relates to the technical field of medicines, and particularly relates to a water-soluble hypocrellin PLGAnanoparticle and a preparation method thereof. The preparation method comprises the following steps: by taking poly(lactic-co-glycolic acid) (PLGA) as a carrier, dissolving PLGA and hypocrellin into an organic solvent to prepare an oil phase, adding into freeze-drying excipient-containing water phase under high-speed stirring, and finally obtaining the hypocrellin nanoparticle by adopting an emulsification freeze-drying method. By using a biodegradable medical polymer material PLGA used in the preparation method and approved by the food and drug administration (FDA) of the United States, the toxic and side effects of a common drug-carrying material can be reduced, the water solubility of the drug can be improved, the particle size of the prepared nanoparticle ranges from 20-200nm, the drug has red shift, the absorption of the nanoparticle in a phototherapy window (600-900nm) can be increased, and the dark toxicity of the drug can be reduced. The preparation method is simple in raw materials and easy to operate.
Owner:NANJING NORMAL UNIVERSITY

Method for establishing animal model for senile dementia, special liquid medicine and dosing device

InactiveCN103284980ATypical behaviorTypical pathological symptomsHydroxy compound active ingredientsMedical devicesSterile environmentSenile dementia
The invention relates to a method for establishing an animal model for senile dementia, a special liquid medicine and a dosing device, and belongs to the technical field of neurosciences. The method comprises the following steps: obtaining positioning coordinates of paraceles according to brain atlases or/and magnetic resonance image data of an experimental animal; respectively burying a conduit of the dosing device in left and right paraceles of the animal, and injecting the special liquid medicine to the paraceles at a constant speed in 14-16 minutes under a sterile environment within 2-3 weeks, wherein the liquid medicine amount is 100-250 ml methanol per day; alternately dosing the left and right paraceles, wherein the dosing frequency is 18-30 hours at an interval; and continuously dosing for 2-10 months to obtain a non-human primate animal model for senile dementia. With the adoption of a novel dosing mode: dosing to the paraceles at the constant speed, medicine can circulate to whole brain through the cerebrospinal fluid to exert the toxic effect, so that peripheral damage by the medicine is avoided. The AD model is established by injecting methanol or formaldehyde to the paraceles, so that behaviors and pathological symptoms are typical, the basic physiological status is good and the individual difference is relatively smaller.
Owner:KUNMING INST OF ZOOLOGY CHINESE ACAD OF SCI

Method of applying nontoxic deforming agent to liquid edible fungus fermentation tank

InactiveCN104073446ALight weightHigh market priceFungiFoam dispersion/preventionManufacturing cost reductionBiotechnology
The invention discloses a method of applying a nontoxic deforming agent to a liquid edible fungus fermentation tank; the liquid edible fungus fermentation tank must be cleaned thoroughly and inspected after every use or before reuse; the method comprises the following steps: boiling the tank to disinfect; adding sucrose, bean flour and a monopotassium phosphate main ingredient to the liquid edible fungus fermentation tank; adding water and stirring; injecting a deforming agent; selecting a proper cultivating process, wherein soybean oil serves as the defoaming agent, and is added and adjusted depending on a volume of 3-8%; the soybean oil, which is lower than polyoxypropylene-polyoxyethylene glycerol ether in specific gravity, is easier to float on surface in a cultivating environment that the fermentation tank is strenuous and is longer to act on an effective area of foam; scientific name of the polyoxypropylene-polyoxyethylene glycerol ether is polyether, and has low toxicity although being under edible grade, while the soybean oil, as edible oil, contains a great amount of linoleic acid which is fatty acid essential to body, free from toxicity and harm and is more suitable for massive use of food-grade fermentation tank products; and market price of the soybean oil is lower than that of the polyoxypropylene-polyoxyethylene glycerol ether, so as to reduce manufacturing cost.
Owner:XUZHOU LVWEI MODERN AGRI TECH CO LTD

Oxidative degradation method for cyanide in cyaniding tailings

InactiveCN107890622AReduce consumptionPromote decomposition and releaseChemical protectionVacuum extractionHigh pressure
The invention relates to an oxidative degradation method for cyanide in cyaniding tailings. The oxidative degradation method comprises the steps that the mass percentage of the water content of the cyaniding tailings obtained after filter pressing is controlled to be 20-30%, stirring is conducted, and three or more of cement, aluminum powder, sulphur powder, sodium perborate and sodium chloride are added, wherein the amount of added chemicals accounts for 2.2-7.7% of the dry weight mass percent of the cyaniding tailings; a trolley is loaded with the materials and then put into a high-pressurereaction still, and after vacuum extraction is conducted on the materials in the high-pressure reaction still, steam is introduced; and after the temperature is raised to 180-200 DEG C, the pressure is maintained for 4.5-10 hours, depressurization is conducted so that the ammonia-containing steam is exhausted, and the residual cyaniding tailings in the high-pressure reaction still can be convertedinto another type of ordinary solid waste through hazardous waste toxicity identification. The degradation method is good in cyanogen removal effect; cyanogen removal is irrelevant with the initial concentration of cyanogen and is relevant with the time and temperature; the cyaniding tailings obtained after treatment can meet the environment protection requirement and be directly reused as a secondary resource; and by means of hazardous waste toxicity leaching identification, the PH value is 7-9, and the density of the total cyanide is 2 mg/L.
Owner:FUJIAN SHUANGQISHAN MINING +1

Drug for treating rheumatoid arthritis

ActiveCN106880789AGood curative effectShorten the timeAnthropod material medical ingredientsAntipyreticAngelica Sinensis RootClinical manifestation
The invention discloses a drug for treating rheumatoid arthritis. The drug is prepared from radix aconiti kusnezoffi preparata, radix aconiti preparata, radix angelicae, asarum, lumbricus, rhizoma arisaematis, flos carthami, yam rhizome, semen coicis, radix angelica sinensis, placenta and ants according to a proper ratio. The medicines are ground into fine powder, and the fine powder is coated with raw honey to form pellets. Due to the fact that the toxicity of the formula is high, the drug needs to be stopped for two days to observe the pharmacodynamic function after being used for one week. The drug has a remarkable curative effect for rheumatoid arthritis, especially when clinical manifestations include symmetrical pain and swelling of multiple joints in the whole body, symmetrical stiffness or tightness of joints, even deformation to different degrees, alternate chills and fever, limb joint and muscular ache, unsmooth flexion and extension, or unstable pain, and even severe pain, swelling, hardness and deformation of joints. Treatment of 200 patients confirmed through blood and modern medical equipment proves that 166 patients are cured, 11 patients are improved, the effective rate is 88.5%, and the cure rate is 83%.
Owner:SHAANXI UNIV OF CHINESE MEDICINE

Nutritional food for treating constipation and reducing internal fat and preparation method thereof

The invention discloses nutritional food for treating constipation and reducing internal fat and a preparation method thereof, and belongs to the technical field of health-care food. The nutritional food for treating constipation and reducing internal fat disclosed by the invention is mainly prepared from the following components: noni fruit enzyme powder, passion fruit enzyme powder, pomegranate enzyme powder, mangosteen enzyme powder, blueberry enzyme powder, amorphophallus albus gum, soybean dietary fiber powder, oat fiber powder, apple fiber powder, fructooligosaccharide and strawberry fruit powder, wherein the passion fruit enzyme powder accounts for 5 parts by weight, the pomegranate enzyme powder accounts for 5 parts by weight, the mangosteen enzyme powder accounts for 5 parts by weight, the blueberry enzyme powder accounts for 10 parts by weight, the amorphophallus albus gum accounts for 10 parts by weight, the soybean dietary fiber powder accounts for 5 parts by weight, the oat fiber powder accounts for 10 parts by weight, and the apple fiber powder accounts for 5 parts by weight. The nutritional food can clear away the toxicity of intestines and eliminate overnight excrement if the nutritional food is eaten for a long time, and has the effects of relieving the bowel, relieving the constipation, tightening up the belly and beautifying the skin, and removing the toxicity; moreover, the nutritional food also can maintain beauty and keep young, and the skin problems such as formation of color spots, acnes and the like can be effectively prevented.
Owner:哈尔滨瑞康源生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products